Immunodiagnostic Systems Holdings PLC (LSE:IDH) - Share price - Overview

Stock Report

Immunodiagnostic Systems Holdings PLC IDH

Last Price
GBX290.00

Day Change
0.00|0.00%

As of 19/01/2018
17:15:00 GMT | GBX
Minimum 15 Minutes Delay.

Last Close290.00p
Day Range286.00 - 286.00
Mkt Cap85.31Mil
52-Wk Range240.00 - 355.00
Yield %0.41
ISINGB00B01YZ052
Volume62,050
P/E18.98
P/S2.13
P/CF10.02

Share Price

Total Returns 22/01/2018

 Chg (%)  
More ...
Immunodiagnostic Systems Holdings PLC7.41 
FTSE 100 TR GBP1.96
 
Financials
201520162017
More ...
Income Statement
Turnover45.3638.3140.04
Operating Profit3.27-36.801.65
Net Profit2.35-32.173.01
Reported EPS8.00-109.7010.20
Balance Sheet
Current Assets40.5543.1848.94
Non Current Assets56.5519.1619.79
Total Assets97.1062.3468.74
Current Liabilities7.196.558.22
Total Liabilities16.6910.7412.00
Total Equity80.4151.6056.73
Cash Flow
Operating Cash Flow8.948.097.64
Net Change in Cash-2.442.384.27
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
2018-------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/08/2017PurchaseRegis Duval305.002,5007,625.00
30/06/2017PurchaseRegis Duval297.009,00026,730.00
27/06/2017PurchaseRegis Duval295.005,19315,319.00
21/06/2017PurchasePaul Martin290.002,1006,090.00

Company Profile

Immunodiagnostic Systems Holdings PLC is a medical device company. Its core products include immunoassays and automated immunoanalyser technologies, which it licenses and sells to other companies.

Sector

Medical Devices

Market Position

963 of 1834 Companies

Index

FTSE AIM All Share

Outlook

(24/11/2017) ceo - "...I am confident that we can improve on this performance moving forward, and I look forward to returning the business to growth"

Next Event 31/03/2018

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0020.4316.98
Div Yld (E)0.001.564.04
PEG (E)0.001.741.27
ROCE5.3619.2517.10
Op Mrgn6.297.931.92
EPS Grwth0.0020.2112.52
Dividends
PreviousLatest
More ...
Record Date22/07/1621/07/17
Ex-Div21/07/1620/07/17
Paid19/08/1618/08/17
Amnt1.204.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr Burkhard Wittek
Chief Executive OfficerMr. Jaap Stuut
Chief Financial Officer & Company SecretPaul Martin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.